ESC Premium Access

Targeting reverse remodelling in heart failure

Event: ESC Congress 2018
Topic: Treatment
Session type: Moderated Posters
Date: 26 August 2018
Time: 10:05 - 10:55

Congress Session

7 presentations in this session

Feasibility and efficacy of early donepezil with or without metoprolol in reperfused myocardial infarction rats

Speaker: Doctor M. Li (Osaka, JP)

The best of two worlds: Vascular protection and decongestion without RAAS stimulation mediated by a novel dual acting V1a/V2 vasopressin receptor antagonist

Speaker: Doctor P. Kolkhof (Wuppertal, DE)

Cardioprotective effects of a novel designer C-type natriuretic peptide-based therapeutic, C53 , for the prevention of post-myocardial infarction heart failure

Speaker: Mr Y. Chen (Rochester, US)

Early administration of empagliflozin preserved heart function in cardiorenal syndrome in rat

Speaker: Doctor H. Yip (Kaohsiung, TW)

Empagliflozin improves left ventricular diastolic function in db/db mice without altering cardiac expression of enzymes relevant for ketone body or branched chain amino acid catabolism.

Speaker: Miss J. Moellmann (Aachen, DE)

Empagliflozin prevention of heart failure development in diabetes is associated with an improvement in cardiac energy producition

Speaker: Professor S. Verma (Toronto, CA)

Dapagliflozin-induced attenuation of cardiac remodeling in rats with Type 1 diabetes mellitus

Speaker: Associate Professor M. Okoshi (Botucatu, BR)

7 speakers from this session

Doctor Meihua Li

National Cerebral and Cardiovascular Center Research Institute, Osaka (Japan)
0 follower

Doctor Peter Kolkhof

BAYER HealthCare, Global Drug Discovery, Cardiology Research, Wuppertal (Germany)
0 follower

Mr Yang Chen

Mayo Clinic, Rochester (United States of America)
0 follower

Doctor Hon-Kan Yip

Chang Gung Memorial Hospital Kaohsiung, Kaohsiung (Taiwan)
0 follower

Miss Julia Moellmann

RWTH University Hospital Aachen, Aachen (Germany)
0 follower

Professor Subodh Verma

St. Michael's Hospital, Toronto (Canada)
20 presentations
0 follower

Associate Professor Marina Okoshi

UNESP, Medical School, Botucatu (Brazil)
0 follower

This platform is supported by

logo Novo Nordisk